
Pharmacokinetic Properties of Once-Daily Oral Low-Dose Mesylate Salt of Paroxetine (LDMP 7.5 mg) Following Single and Multiple Doses in Healthy Postmenopausal Women
Keywords: mesylate; paroxetine; pharmacokinetics; menopause; vasomotor symptoms; women